Home / Netherlands / Core Laboratories N.V.
Core Laboratories N.V.
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
157 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Core Laboratories N.V. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| February 15, 2013 | Balyasny Asset Management LP | 0.96% | |
| February 13, 2013 | Balyasny Asset Management LP | 1.04% | |
| February 8, 2013 | Balyasny Asset Management LP | 1.19% | |
| January 25, 2013 | GLG Partners LP | 0.51% | |
| January 3, 2013 | Balyasny Asset Management LP | 1.47% | |
| December 31, 2012 | Balyasny Asset Management LP | 1.38% | |
| November 1, 2012 | Balyasny Asset Management LP | 1.03% |
Download 157 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.59% of the capital sold short
- Signify N.V. 7.52% of the capital sold short
- Pharming Group N.V. 7.39% of the capital sold short
- Imcd N.V. 4.75% of the capital sold short
- Fugro N.V. 3.69% of the capital sold short
- DSM-Firmenich AG 3.48% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- NSI N.V. 2.59% of the capital sold short
- PostNL N.V. 2.04% of the capital sold short
- Alfen N.V. 1.98% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- Sligro Food Group N.V. 1.55% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Core Laboratories N.V., source AFM, data as at July 1, 2015, https://www.quivad.com/action/core-laboratories-n-v?page=4